A detailed history of Pacific Capital Wealth Advisors, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Pacific Capital Wealth Advisors, Inc holds 382 shares of NVO stock, worth $32,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares
382
Previous 254 50.39%
Holding current value
$32,470
Previous $36,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $15,240 - $18,613
128 Added 50.39%
382 $45,000
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $26,259 - $31,438
214 Added 535.0%
254 $36,000
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $4,084 - $5,436
40 New
40 $5,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pacific Capital Wealth Advisors, Inc Portfolio

Follow Pacific Capital Wealth Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Capital Wealth Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Capital Wealth Advisors, Inc with notifications on news.